Heap spraying is a technique attackers use to make certain memory corruption bugs more reliable. It is most often discussed in the context of browsers and scripting environments, but the real lesson for MedTech is broader: if your product or its ecosystem includes memory-unsafe components, you need layered defenses that reduce exploitability and improve detection.
This article is written for defensive purposes. It explains the risk at a high level and focuses on practical mitigations you can implement and document.
What is heap spraying?
Heap spraying is a way to “flood” a process’s heap with attacker-controlled data so that if a vulnerability redirects execution into memory, the attacker has a higher chance of landing on something useful. Heap spraying is not usually the vulnerability by itself. It is often a reliability booster that makes an existing bug easier to exploit.
Why heap spraying matters in medical device ecosystems
Even if your device does not run a browser, heap spraying still matters because many medical device ecosystems include components where memory bugs can occur:
- Device-side software built in C or C++ (or using native libraries)
- Companion applications on Windows, Linux, iOS, Android, or embedded HMI stacks
- Update tooling and installers
- Third-party components (parsers, media libraries, image libraries, networking stacks)
When memory exploitation succeeds, the outcomes can include loss of availability, unauthorized changes to settings, access to sensitive data, or compromise of update mechanisms. That is why the FDA expects a secure-by-design approach, supported by evidence, across the total product lifecycle. See the FDA premarket cybersecurity guidance here: Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions.
The practical defense playbook
1) Patch and reduce exposure first
The simplest way to reduce heap spraying risk is to reduce the number of exploitable bugs in shipped code and reduce reachable attack surface.
- Keep third-party components current and track them with an SBOM.
- Remove or disable unused parsers, protocols, and features.
- Harden default configurations so untrusted inputs are limited.
If you need help building an FDA-ready SBOM program, see FDA-compliant SBOM services for MedTech.
2) Turn on modern exploit mitigations where your platform supports them
Heap spraying becomes less useful when the platform makes memory layout harder to predict and blocks code execution from data memory. Controls to prioritize include DEP and ASLR, plus additional platform mitigations when available (for example, Control Flow Guard on Windows). Microsoft provides a practical guide to enabling Exploit Protection: Turn on exploit protection to help mitigate against attacks.
From a governance perspective, NIST also calls out memory protection concepts such as DEP and ASLR in its security control catalog (SI family). Reference: NIST SP 800-53 Rev. 5 (Update 1).
3) Build secure coding rules into your development process
Most heap spraying risk comes from memory corruption weaknesses upstream. In practice, your biggest wins come from reducing those weaknesses during design and implementation.
- Adopt secure coding rules and enforce them in code review and static analysis.
- Prefer safe APIs and safe parsing patterns.
- Use compiler hardening options and remove dangerous defaults where possible.
A solid reference point for secure coding expectations is the SEI CERT secure coding standards: SEI CERT Coding Standards.
4) Add exploitability-focused testing to your verification strategy
Memory bugs often hide until the right inputs show up. The goal is to force them to show up in test environments.
- Fuzzing for parsers and interfaces that process untrusted input (files, messages, network traffic).
- Sanitizer builds during testing to catch heap overflows, use-after-free, and related issues earlier.
- Targeted security testing for high-risk interfaces and third-party components.
For sanitizer guidance, see the LLVM AddressSanitizer documentation: AddressSanitizer. For a testing-oriented view of heap issues, OWASP’s Web Security Testing Guide includes relevant background on heap flaws: OWASP WSTG: Testing for Heap Overflow.
If you need FDA-aligned testing and reporting, see medical device cybersecurity penetration testing and our overview of types of penetration testing for medical device cybersecurity.
5) Treat heap spraying as a design signal, not just an “IT security” problem
Heap spraying often shows up when the attacker has a way to shape memory (for example, through a scripting engine or repeated allocations). That points to architectural questions:
- Where do untrusted inputs enter the system?
- Where are trust boundaries and privilege boundaries?
- What components run with high privilege that should be isolated?
- What failure modes affect safety or essential performance?
That is why threat modeling pays off early. If you want help mapping these attack paths to mitigations and test evidence, see medical device threat modeling services and secure MedTech product design consulting.
What to document for FDA-facing credibility
For premarket submissions, heap spraying is not something you “submit” directly. What you submit is the evidence that you have reduced exploitability and can detect and respond to issues over the lifecycle.
- Architecture and trust boundaries: where memory-unsafe components exist and how they are isolated.
- Security risk management: threats tied to memory corruption and their clinical impact where applicable.
- Security controls: platform exploit protections, least privilege, secure update design.
- Verification evidence: fuzzing, sanitizer results, targeted security testing, and remediation records.
- Lifecycle plan: patching, SBOM monitoring, vulnerability handling, and coordinated disclosure readiness.
If you want a structured way to organize submission artifacts, this walkthrough helps: Navigating the FDA’s 18 cybersecurity deliverables. For full-service support, see FDA premarket cybersecurity services and FDA postmarket cybersecurity services.
Key takeaways
- Heap spraying is usually a reliability technique that makes memory corruption exploits more likely to succeed.
- Defenses are layered: patching, reduced attack surface, exploit mitigations, secure coding, and exploitability-focused testing.
- Sanitizers and fuzzing help you find heap bugs earlier, before they become field issues.
- FDA reviewers care less about the term “heap spraying” and more about your documented controls and verification evidence.
FAQs
Is heap spraying a vulnerability?
Usually no. It is typically a technique that improves exploit reliability when a separate memory corruption vulnerability exists.
Do ASLR and DEP stop heap spraying?
They reduce exploitability by making memory harder to predict and blocking common execution paths, but they are not a complete solution. You still need secure coding, testing, and patching.
What testing is most useful for heap-related issues?
Fuzzing for input-heavy components, sanitizer builds in test environments, and targeted security testing on high-risk interfaces.
How should we handle heap risk in third-party libraries?
Track dependencies with an SBOM, monitor for vulnerabilities, patch quickly, and validate the impact with regression and security testing.
How do we explain this in an FDA submission?
Focus on the threat model, the controls that reduce exploitability (mitigations and isolation), and the verification evidence that proves those controls work.
Book a Discovery Session
If you want help reducing memory corruption risk and turning your mitigations and testing into clean, reviewer-friendly evidence, we can help.
Conclusion
Heap spraying is a useful reminder that memory corruption risk is not just about “a bug.” Attackers care about reliability, and they use techniques that turn small weaknesses into repeatable compromise. For MedTech teams, the practical response is clear: reduce the bug surface, turn on platform mitigations, test like an attacker would (safely), and document the results in a way that supports both patient safety and regulatory expectations.